FEATURING REPRESENTATIVES FROM GLOBAL SCIENTIFIC; COMMUNITIES, US POLITICIANS, INVENTORS, ECONOMISTS,CIVIL SOCIETY, CARE GIVERS, PHYSICIANS, MEMBERS OF THE PRESS, EBOLA SURVIVORS, AND REPRESENTATIVES FROM AFRICAN COMMUNITIES. This report was a collaborative effort of the following entities: Millennium Development Goals on AVTELEFORUM | African Health Dialogues (AVTELEFORUM) | African Community Public Health Coalition | Diaspora Liberian Emergency Response Task Force on the Ebola Crisis

1. Candid Assessment of U.S. Response to
the Ebola Crisis at Home and Abroad

2. LINKING
TRANSFORMATIVE
STRATEGIES
WITH
CULTURAL HARMONY
THROUGH
COLLABORATIVE GLOBAL
INTELLIGENCE AND
MEDIA
www.bit.ly/Ebolaassessment
AV Teleforum brings people and experts from
all over the world together to discuss adverse
issues affecting societies in order to advocate
understanding as well as encourage and
generate ideas for sustainable solutions.

3. www.bit.ly/Ebolaassessment
African Views thanks all participants and audience for making this date special in the
tenure of AV Teleforum, and for us -- a day to be remembered, Thank you!

4. STEERING COMMITTEE:
MRS. SENAIT ADMASSU
DR. DOUGBEY CHRIS NYAN
DR. EZI MECHA
CONVENOR:
PADMINI MURTHY M.D., M.P.H., M.S., CHES
PRODUCER & DIRECTOR:
MR. WALE IDRIS AJIBADE
MODERATOR:
REGINA ASKIA WILLIAMS, RN

5. This report was a collaborative effort of the following entities:
Millennium Development Goals on AVTELEFORUM | African Health Dialogues
(AVTELEFORUM) | African Community Public Health Coalition | Diaspora Liberian
Emergency Response Task Force on the Ebola Crisis
www.bit.ly/Ebolaassessment
FEATURING REPRESENTATIVES FROM GLOBAL SCIENTIFIC
COMMUNITIES, US POLITICIANS, INVENTORS, ECONOMISTS,
CIVIL SOCIETY, CARE GIVERS, PHYSICIANS, MEMBERS OF THE
PRESS, EBOLA SURVIVORS, AND REPRESENTATIVES FROM
AFRICAN COMMUNITIES.

6. SCIENTIFIC COMMITTEE
Kathleen Austria, Jonta Williams, Dr. Aileen Marty, Professor, Dr. Paula Tavrow, Dr.
Thambiah Sundaram, Dr. Julius Garvey, , Jason Small, Nancy Lindborg, Dr. Beth Bell, Dr.
Charles Senessie, Dr Oladipupo Sule, Dr. Vamsi Vasireddy, Dr. Robert Amler, Dr.Shelley
Ross, Gill Bodog, Dr.
GOVERNMENT
Senator Cory Booker, Mayor Joseph Makhandal Champagne, Gayle Smith, Congress Woman
Yvette Clarke, Senator Bill Perkins, Council Woman Karen Bass, Assemblyman Carmelo
Garcia,
ECONOMISTS INTELLIGENCE
Dr. Katch Ononuju, Tunji Koko Baoku, Wale Idris Ajibade
FAITH BASED/CIVIL SOCIETY
Mark Ridely-​Thomas, Dr. Prosper Ateba Bouli, William Verdone, Chris Okafor,
Dr. Ezi Mecha, Evelyn Joe, Wilson Wang, Dr. Orland Bishop, Senait Admassu
INVITED DIGNITARIES

7. Padmini Murthy
M.D., M.P.H., M.S.,
CHES
Dr Padmini (Mini) Murthy, Associate Professor in
Health Policy and Management and Family and
Community Medicine and Global Health Director is a
physician and an activist who did her residency in
Obstetrics and Gynecology. She has practiced medicine
and public health for the past 25 years in various
countries. She is the NGO Alt Representative of Medical
Women International Association to the United
Nations, and Committee of the NGO CSW Committee of
NY at the United Nations.
Read more

8. Regina Askia Williams, RN
Regina Askia-Williams is a Nigerian-born, American-
based registered nurse (RN), healthcare and
educational activist, television producer, writer and
public speaker, and widely known Nigerian actress
and model. Askia- She is the host of African Health
dialogues, an AV Teleforum which examines health
issues on the African continent. Askia is also a
contributor to the "Saturday Clinic" series in the
Nigerian newspaper This Day.
Read more

9. Senait Admassu
Mrs. Senait Admassu is the founder of the African
Communities Public Health Coalition (ACPHC), a Los Angeles
based nonprofit organization. Ms. Admassu is extensively
recognized for her expertise. She assisted the Los Angeles
County Department of Mental Health (LACDMH) African/
African America (AAA) Under Represented Ethnic Population
(UREP) subcommittee in assessing mental health service
provision in the African Communities. Ms. Admassu
currently serves on the LACDMH AAA-UREP subcommittee
as a cultural broker.
Read more

10. Dougbeh Chris Nyan,
M.D.(Inventor/ Research
Scientist at NIH)
Dougbeh-Chris Nyan, M.D. is medical doctor and a biomedical
research scientist of Liberian origin. Dr. Nyan specializes in
infectious disease diagnostics. His expertise focuses on
developing simple and rapid diagnostic tests for detecting blood-
borne infections/pathogens such as HIV, Hepatitis B virus,
Hepatitis C virus, Hepatitis E virus, Dengue virus, West Nile virus,
and Chikungunya virus. Dr. Nyan is currently a scientist at the
Laboratory of Emerging Pathogens of the Division of Emerging
and Transfusion Transmitted Diseases at the US Food and Drug
Administration (FDA). He recently testified to US House
committee on Ebola alongside Dr. Brantly
Read more

11. Dr. Ezi Mecha
Dr. Ezi Mecha is the founder & CEO of World Ebony
Network, a nonprofit organization, formed to promote the
good aspects of Afro-centric practices as a way to strengthen
the African family and appreciate the good aspects of other
cultures. She has served in Afghanistan, Iraq, Kuwait, Qatar
providing technical support to US troops .
She is currently working on Ebola humanitarian effort to
collect medical supplies and ship them to affected areas in
West Africa.
Read more

12. Dr. Vamsi Vasirredy
Dr. Vamsi Vasireddy is currently assigned as a Senior Health
Advisor for the Centers for Disease Control and prevention (CDC)
based in Tanzania. Prior to this position, Vamsi served as the
Principal Investigator for a project funded by the Bill & Melinda
Gates Foundation to strengthen access to antimalarial medicines
across ten countries in Africa and Asia. Vamsi has the distinction
of designing and implementing the first comprehensive health
systems strengthening framework for Liberia, and conducting the
first health systems assessment of district health departments in
Israel. Vamsi has worked for multiple donors such as USAID,
CDC, DHHS, European Union, and UKAID. Vamsi is a medical
doctor with advanced degrees in public health. While not
working in multiple countries and volunteering for public health
organizations, he likes to travel and explore history and various
global cuisines.
Read more

13. Robert W. Amler, MD,
MBA
Robert W. Amler, MD, MBA is vice president for government
affairs at NYMC and the dean of the School of Health Sciences
and Practice, and Institute of Public Health. He is the former
regional health administrator for the US Department of Health
and Human Services, where he secured $260 million in Medicaid
supplemental for New York, New Jersey, and Puerto Rico.
A 25-year veteran of the US Public Health Service, Dr. Amler
oversaw more than 100 field investigations of infectious diseases
and environmental chemical exposures throughout the United
States and has served as advisor to the US Surgeon General and
EPA Administrator on a broad range of medical, environmental,
and health policy issues. He is a practicing physician, board-
certified in both pediatrics and preventive medicine.
Read more

14. Paula Tavrow, PhD, MSc,
MALD
Paula Tavrow, PhD, MSc,
Program in Population and Reproductive Health and Adjunct
Associate Professor in the Community Health Sciences
Department at the UCLA School of Public Health. She also serves
as Co-
research interests center on adolescent reproductive health,
coerced sex, early marriage, domestic violence and the quality of
primary health care in Africa. Prior to coming to UCLA in 2002,
Dr. Tavrow was the Deputy Research Director for the USAID-
funded global Quality Assurance Project (1997-2001). She
oversaw eleven operations research projects to improve the
quality of rural health services in Kenya, Malawi, South Africa,
Uganda, Zambia and Zimbabwe. Dr. Tavrow also has served as a
health advisor and researcher at the University of
Malawi Read more

15. Dr. Shelley Ross
Dr. Shelley Ross is a Family Physician in Canada with an
President of her provincial medical association, the British
Columbia Medical Association.
She is a past president of MWIA and the Federation of Medical
Women of Canada. She began her work with MWIA as a Young
Forum member at the MWIA Congress in Vancouver in 1984.
Read more

16. Dr. Thambiah
Sundaram
Dr. Thambiah Sundaram has been involved in public health research
for many years. He with his wife, Dr. Nalini Sundaram, a
microbiologist have established a medical device company and a
laboratory in the United States. In that lab, they have developed the
first mail in spore test kit in the world used for validating all types of
sterilizers in the health care facilities. This medical device is also
used by the University of California Los Angeles for testing of their
sterilizers in their dental school and their health departments.
In response to the pervasive allergenic environment, Dr. Sundaram
and his group decided to research for a disinfectant that would not
cause similar allergies as the existing ones. His goal was to invent
one that was both non-allergenic and safe for the environment..
The amazing discovery about this product is, that it can be used
across the board in various industries to clean, decontaminate,
disinfect and preserve environments affected by the EBOLA VIRUS.
Read more

17. Dr. Katch Ononuju
Dr. Katch Ononuju is an Economist and Public Affairs
Analyst. He is the Managing Director/ Chief Economist
at iordinance, which is into economic consultancy, large
scale military hardware supply and security consultancy.
He is also a Public Affairs Analyst with a doctorate
degree from the prestigious London School of
Economics and Political Science. Interestingly, he is also
a politician and chieftain of the ruling PDP. He ran
against Olisa Metuh for the position of National Publicity
Secretary of the party.
Read more

18. Assemblyman Carmelo G.
Garcia, MSIS
Carmelo was the first minority representative to be appointed to
serve as the Director of Health and Human Services for the City
of Hoboken. The commitment displayed during his tenure
created progress and positive change experienced by numerous
residents, in addition to the impact his management had for
taxpayers, the underprivileged, seniors, disabled persons and
children. In 2007, Garcia left his position as Hoboken Director of
Health and Human Services when he was hired as deputy
director at the Hoboken Housing Authority. He was selected after
a national selection process that brought in hundreds of
candidates. In May 2009, Mr. Garcia was appointed as executive
director of the very same housing authority where he grew up
Driven,
Disciplined, Determined and Diligence.
Read more

19. DR OLADIPUPO S. SULE
Obtained his medical practice license from the University of
Lagos, College of Medicine in 1985. He worked in various
hospitals and in 1991, he established Lafia Hospital which has
grown to become a Group of Hospitals with 2 locations in Ibadan
municipality of Oyo State. In 2007, he established a health
Insurance company called Nonsuch Medicare Limited which is
duly accredited by the National Health Insurance Scheme (NHIS)
to cater for the health care needs of individuals and corporate
organizations nationwide. The company has over 300 hospitals
under its network nationwide to cater for the health care needs
of the citizens. He is currently the Managing Director/CEO of
Nonsuch Medicare Limited and Chairman Lafia Group of
Hospitals. He is an Associate member of the General and Private
Medical Practitioners of Nigeria. He has attended various medical
courses and seminars both locally and internationally. B.
Read more

20. Wale Idris Ajibade
Founder and Executive Director of African Views
Organization and the architect of the AV framework, which
includes African cultural exchange program for children, a
program that connects classrooms in Africa by age groups
with classrooms abroad through Skype as well as the PINK
Africa - African Women Advancement transformative project.
He is the director and executive producer of the AV
Teleforums which includes, African Health Dialogues, Youth
Initiatives, Millennium Development Goals, Green Africa,
Culture Diplomats, New Deals, Future of Women. Read more

22. The Ebola outbreak currently ravaging parts of West Africa
is the most severe acute public health emergency in
modern times. Never before in recent history has a
biosafety level 4 pathogen infected so many people so
quickly, over such a wide geographical area, for so long.
Since obvious signs of infectious may not be noticeable during the Ebola Virus Disease
(EVD) incubation, which may be 2 21 days, makes it possible for a carrier to cross
international borders undetected and increase the risk of transmission as well as posing a
global threat.
The West African strain of EVD has ravaged Liberia and Sierra Leone since the recent
outbreak believed to have begun in Guinea in December 2013. And has reached Mali,
Spain, United States of America, United Kingdom, Democratic Republic of Congo
(DRC*2014), Senegal, and Nigeria.

23. SIGNS AND SYMPTOMS OF EBOLA
After about 5
days.
• Sudden fever
• chills
• muscle aches
• diarrhea,
• nausea
• vomiting
• Bodily pain
• mental confusion,
• jaundice (yellow
skin)
• severe weight loss,
• bleeding inside and
outside the body
• shock, and multi-
organ failure

24. RETRACING EBOLA TO PATIENT ZERO
Why it's so important
to find patient zero?

25. The Ebola virus is still spreading
in West Africa, especially in
Sierra Leone, and the number of
known cases globally has now
exceeded 20,000, according to
the World Health Organization
(WHO) December 2014.

27. The alarmist nature of the American tabloids and cable news is causing anxiety and
spreading fear and misinformation about the EVD. Health-​care costs and illness from
the effects of the disease contribute relatively little to its economic impact, according to
a World Bank report. Rather, eighty to ninety per cent of the economic effects are due
portation systems, including ports and
airports, and keeps people away from their jobs. Fear factor about the possible spread
of Ebola Virus Diseases within America copulated with the exponential increment in
official reported numbers of fatalities in Africa is causing great shift in public percep-
tion and law mak ferent responses to the situation across the board. Protests
erupted in Spain where a dog named Excalibur who belonged to an Ebola-​infected
nurse was destroyed.
In Africa, the story of Ebola is a test of human compassion and a destruction of ways of
life. People are not dying because they are ignorant, rather because in spite of the risks
involved, they still choose to care for their loved ones. These are people who simply
cannot sit and watch their mothers, children, sisters, brothers, fathers, and friends die
and do nothing. Many of these people die because they choose love. With hospitals
turning patients away and isolation centers in short supply, the choices people have are
limited. Women and children carry a greater burden of Ebola scourge.
The United Nations' complained about anti-African prejudices arising from the crisis,
and warned against ill-conceived quarantine enforcements and discriminatory travel
restrictions.
Ebola fear causes
stigma against West
Africans
COST OF MISCONCEPTIONS AND MISINFORMATION

28. The program was dedi-
cated to the brave first
responders who met their
fates while engaging in
collective sacrificial ser-
vices and effort to save
lives and to tame the
scourge of the EVD. We
owe this people a depth of
gratitude for putting the
need of others ahead of
their own.
May peace be with them.
THANK YOU!
HEALTHCARE PERSONNEL ON THE FRONT LINE

29. As hospitals in many areas are
overstretched , interventions from the
three hardest-hit countries, Guinea,
Liberia, and Sierra Leone, clearly stated
that international assistance is both
greatly needed and fully welcomed.
Though part of the job of the caregiver
is dispelling misconceptions, yet some
US legislators are reacting to public
sentiment and enforcing mandatory
quarantine on returning Ebola volunteers
within their jurisdiction. This can be seen
as an effort to secure the public safety,
but at the cost of civil liberty.
The American Civil Liberties Union was
worried that if people going to help in
Ebola infected areas are really doing the
right thing and are met with hostility, it
is not an encouraging signal for those
who might wish serve. Volunteer
responders deserve gratitude and
respect.
HEALTHCARE PERSONNEL ON THE FRONT LINE

30. So far more than a 1000 people are in
quarantine across the US. See quarantine laws

31. EMERGENCY MEDICAL SERVICES (EMS) AND EBOLA PREPAREDNESS
Body Fluids:
• Blood
• Vomit
• Feces
• Urine
• Saliva
• Breast milk
• Sweat
• Semen
The virus is
spread through
body fluids.

32. STRAINS AND CASES OF EBOLA
1. Bundibugyo Ebola virus (BDBV)
2. Zaire Ebola virus (EBOV)
3. Reston Ebola virus (RESTV)/
4. Sudan Ebola virus (SUDV)
5. Taï Forest Ebola virus (TAFV)
Ebola Virus Disease (EVD) was first identified in 1976, when it first appeared in 1976 in 2 simultaneous outbreaks, in
Nzara, Sudan, and in Yambuku, Democratic Republic of Congo. The virus is named after the Ebola River, which runs near
the Congolese village where one of the first outbreaks happened. Genus Ebola virus is 1 of 3 members of the Filoviridae
family (filovirus), along with genus Marburgvirus and genus Cuevavirus. Genus Ebola virus comprises 5 distinct species:
BDBV, EBOV, and SUDV have been associated with large EVD outbreaks in Africa, whereas RESTV and TAFV have not.
The RESTV species, found in Philip lic of China. The virus causing the 2014 west African
outbreak belongs to the Zaire species.
Six countries have been affected:
Outbreak control now focused primarily
in Guinea, Liberia, and Sierra Leone.
After 20 cases, Nigeria has had no new
cases since September 5, 2014.
1 case in Senegal
1 case in Spain
3 cases in Dallas, Texas
1 case in New York City
1 Case in Glasgow

35. EBOLA TIMELINE IN AMERICA

36. US GOVERNMENT RESPONSE
Since the first cases of Ebola were reported in West Africa in March 2014, the
United States has mounted a whole-of-government response to contain and
eliminate the epidemic at its source, while also taking prudent measures at home.
The President last month outlined a stepped-up U.S. response, leveraging more
thoroughly the unique capabilities of the U.S. military to support the civilian-led
response in West Africa. Domestically, we have prepared for the diagnosis of an
Ebola case on U.S. soil and have measures in place to stop this and any potential
future cases in their tracks.
US strategy and Key goals:
1. Controlling the epidemic at its source in West Africa;
2. Mitigating second-order impacts, including blunting the economic, social, and
political tolls in the region;
3. Engaging and coordinating with a broader global audience; and,
4. Fortifying global health security infrastructure in the region and beyond,
including within the United States (The White House)

37. THE PRESIDENT’S APPEAL
The President underscored the indispensability of the mission to treat national and
international healthcare workers who fall ill with Ebola in their brave service to others. He thanked the
members of the Corps as well as their families for taking on this challenge, commenting that, of the 71
officers selected, all of them accepted the assignment, a testament to their selfless service to the nation.
Click here to see the Emergency Appropriations Request letter to the Congress.

38. EMERGENCY FUNDING REQUEST
The Administration asked for $6.18 billion emergency funding request but received $5.4 billion from
the Congress to enhance comprehensive efforts to address this urgent situation. To help meet both
immediate and longer-term requirements, $4.64 billion is requested for immediate response and $1.54
billion is requested as a Contingency Fund to ensure that there are resources available to meet the
evolving nature of the epidemic. Here is the synopsis of how the money should be distributed:
• Department of Health and Human Services (HHS) - $2.43 billion:
• Centers for Disease Control and Prevention (CDC) - $1.83 billion.
• Public Health and Social Services Emergency Fund (PHSSEF) - $333 million.
• $157 million for the Biomedical Advanced Research and Development Authority (BARDA)
• $10 million to aid in modeling and genetic sequencing of the Ebola virus.
• National Institutes of Health - $238 million. The request includes funding for immediate response for
advanced clinical trials to evaluate the safety and efficacy of investigational vaccines and therapeutics.
• Food and Drug Administration - $25 million.
• U.S. Agency for International Development - $1.98 billion: Department of State - $127 million:
• Department of Defense - $112 million: The request includes funding for the Defense Advanced Research
Projects Agency (DARPA)
• Contingency Fund: The Administration is requesting $1.54 billion for a Contingency Fund, with $751
million for HHS and $792 million for USAID and the Department of State.

39. U.S. Department of State Engages African Diaspora Communities on the U.S. Response to the Ebola Crisis
In October 2014, Affairs hosted a conference call with over 200
crisis. Individuals representing Sierra Leone, Liberian, Nigerian, Senegalese and other diaspora communities
participated from several states across the country, including Maryland, Minnesota, Connecticut, and
Arizona.
response and listened to their ideas and suggestions about how the government can coordinate with African
diaspora communities across the United States. Here are the Q & As
Q: How is the United States working with the African Union to combat this epidemic?
A: The US is working very closely with the African Union to respond to this epidemic., the need for qualified healthcare
workers, trained responders and with up to $10 million in support.
Q: What is being done today to help neighboring countries of the Ebola-affected countries to improve
readiness for this disease? A: The U.S. Agency for International Development (USAID) is working alongside other
government agencies to develop an Ebola Preparedness Strategy
Q: Is there a plan to have a central platform where diaspora members can contribute financially to this
effort? A: A list of NGOs working in West Africa is available here.
Q: How is the U.S. government engaging African diaspora communities in the United States?
A: Agency officials throughout the U.S. government are working together to engage diaspora communities via conference
calls, speaker presentations, social media events, and by sharing timely and accurate information about what is

40. THE WORLD BANK MEETING: A Perspective from the Countries
WATCH NOW

41. SEVERITY OF THE PROBLEM

42. ECONOMIC IMPACT OF THE EBOLA

43. A Gap Assessment on Knowledge
Study and geographical focus
Dimensions/variables
covered
Methodology Results
World Bank - Economic impact the
3 affected countries; short term and
medium term study
-GDP; -fiscal effect/financing
gap; -inflation; -investment; -
capital flight; exchange rate
Sector components Model
which allows experimenting
with various scenarios (e.g.
low Ebola and high Ebola)
Ebola led to downward revision of the 2014 growth
of Liberia (from 5.9% to 2.5%), Sierra Leone (from
11.3% to 8%) and Guinea (from 4.5% to 2.4%). The
growth prospects for 2015, respectively, are -4.9%,
3% and 2%.
UNDP (Sierra Leone / Guinea Economic and social impact
Narrative analysis (Sierra
Leone) of several sectors
Multisectoral Consequences
WHO (the affected countries; 9
months of Ebola and projection to
November 2014)
Health and health systems
(New England J. of
Medicine)
Forecasting tools
70.8% fatality rate; If not treated the # of Ebola
cases will be 20,000 in all countries.
World Association of Universities -
West Africa
Impact on higher education
Data from various universities
for descriptive analysis
-negative for the higher education sector;
Knowledge workers are being withdrawn.
The Economist (Ebola’s economic
impact-September 3)
Health, education, trade and
growth
-
GDP declines, food shortage, supply of teachers
decreases, decline in savings, investment/capital
accumulation
WFP (Rapid Assessment)- Senegal Trade Rapid appraisal
50% drop in cross-border trade, fruit and palm oil
no longer available on border markets with Guinea
CDC (estimating the scale of EVD) Prevalence of EVD
Computational and other
modelling tools
8,000 cases in S. Leone; `16,000 cases in Liberia;
550,000 cases without intervention; 1.4million by
January
FDC (finance derivatives company)- Tourism; Aviation ; Health;

50. IN-KIND INTEL AND MEDICAL SUPPLIES

51. IMPLEMENTING PARTNERS

52. AFRICAN UNION RESPONSE TO THE EBOLA EPIDEMIC IN WEST AFRICA
MEETING OF MINISTERS OF HEALTH
The AU response to Ebola started in April 2014 at the first 1st African Ministers of Health
Meeting jointly convened by the African Union Commission (AUC) and the World Health
Organization (WHO) in Luanda, Angola. A strong Communiqué and an appeal to Member
States with experience in handling Ebola disease to assist were issued. The response was
positive. Some AU Member States sent experts to the affected countries.
AU AND AUC STAFF MEMBERS PROVIDE FUNDS FOR EBOLA RESPONSE
$1, 000 000 was released from the Union’s Special Emergency Assistance Fund for
Drought and Famine in Africa in August 2014. The use of these funds is determined by the
funding agreement with the Member States.
DECISIONS OF THE AU PEACE AND SECURITY COUNCIL
The Peace and Security Council of the AU met at its 450th meeting in Addis Ababa on 19
August 2014, and adopted decisions on the Ebola outbreak in West Africa:

53. AFRICAN UNION RESPONSE TO THE EBOLA EPIDEMIC IN WEST AFRICA
Two key decisions of the Peace and Security Council were:
To authorize the immediate deployment of an AU-led Military and Civilian Humanitarian
Mission, comprising medical doctors, nurses and other medical and paramedical
personnel, as well as military personnel, as required for the effectiveness and protection of
the Mission: and,
That the Commission should take, without further delay, the necessary steps to develop a
Concept of Operations for the AU Mission, including its logistical, financial and other
relevant aspect. The full communiqué of the PSC is available on here and full decisions are
available here
DECISIONS:
• Lifting of travel restrictions
• Engagement with media and other key stakeholders
• Mobilization of adequate resources
• Establishment of an African Center for Disease Control

54. LESSONS LEARNED
As some experts noted, never again can the
international community allow what boils down
to “market failure” to create such catastrophic
suffering for humanity in any country, in any
region of the world.
The sense of urgency and need for speed, without
compromising the integrity of studies or the
quality of their data, are fully justified by the dire
situation in affected countries and the risk that
other countries may soon experience their first
imported cases.

55. Economic ConsequencesSocial Consequences
Ebola Virus Disease Outbreak
Increased
Morbidity
Increased
Mortality
Increased
Pressure on
Health
Systems
Not tending to
Regular
Pathologies –
malaria,
vaccinations, etc.
Incremental
Costs to
Health
Systems
Reduced
School
Attendance
Incremental
Dropouts
Decrease in
Educational
Outcomes
Incremental Costs to
Governments and
Society
Decrease on
Health
Outcomes
Increased
Labor
Absenteeism
Changes in
Domestic
Consumption
Patterns
Changes in
Production
Patterns
Agricultural
Industry
Mining
Knowledge
Transfer /
Meetings
Changes in
International
Consumption
Patterns
Transport
Trade
Tourism
Household
Income, Food
and Nutrition
Investment
Patterns
Changes in
Capital
Flows
Migration
Africa's Integration
and Transformation
Cohesion
Governance
/ Security
Stigma
Risk
Perceptions
Uncertainty
Gender
Reduced
Outcomes
on Social
Protection
Intra African and
Intercontinental
Trade

56. WHAT CAN BE DONE TO STOP THE OUTBREAK AT SOURCE?
Find:
Find and diagnose patients.
Respond:
Isolate patients, find and
monitor patient contacts.
Prevent:
Healthcare infection control,
avoid risk factors

59. In order to Control the epidemic in the
hardest hit areas in Africa, the global
community must implement tenable or
sustainable strategy.
The global community must consider
establishing well secured global
standard emerging infectious diseases
research and control centers in
selective countries across all regions of
Africa.

60. Establishing such institutes will help improve global health security
capacity in vulnerable countries in preventing, detecting, and rapidly
responding to outbreaks before they become epidemics.
How will this unprecedented
outbreak change globalization
trends and the African landscape?

61. • 1 Aug: WHO and the government of Sierra
Leone, Guinea and Liberia launched a joint US$
100 million response plan.
• 8 Aug: WHO declared the Ebola outbreak in
West Africa a Public Health Emergency of
International Concern (PHEIC).
• 28 Aug: WHO issued a "roadmap" to scale up
the international response.
• 19 Sep: UN Mission for Ebola Emergency
Response (UNMEER)established.
• 17 Oct: WHO declared Senegal free of Ebola
virus transmission.
• 20 Oct: WHO declared Nigeria free of Ebola
virus transmission.
• 24 Oct: Mali confirmed its first case of Ebola.
• Latest WHO Ebola response roadmap -
Situation report

62. What window of opportunity
does the Ebola crisis in West
Africa presents to improve the
goal of global peace and
stability?

63. The current chaos in Africa presents a great window of
new health infrastructure with global standard. The current
pledges from various countries provides the much needed seed
and the presence of so many health expatriates makes now the
best time to implement such an idea.
The current situation provides many countries the opportunity to establish own
centers, which often ends in self-interest and scrambling for resources leaving
regional instability in its wake In the aftermath.
RISK OF FAILURE

64. The International community must work together with
selective countries in Africa to develop a multi-partners
funded operations and integral global network system
management of such institutes. An Integral global
standard health institute is a real need in Africa and a
peace of mind to the rest of the world.
We propose to have a follow-up tele-forum on the risks and
benefit of establishing such health institutes in Africa.
BENEFIT OUTWEIGHTS THE RISK

65. It is also important to recognize treatment obstacles and the effort that concerned-
civilians are making towards the progress in removing those obstacles and stopping
Ebola everywhere.
DR DOUBEY CHRIS NYAN: Patented a diagnostic tool that can detect Ebola and other infectious
diseases in a patient within 30 minutes and looking for funding to develop. His work can help
tremendously in controlling transmission and treatment of EVD Ebola. He has been published in
the journal of Medicine under “Clinical Infectious Diseases.” Contact
DR SUNDARAM: Invented a non-allergenic and environmentally safe disinfectant capable of
decontaminating Ebola residue in dwelling which is key component to control of EVD. Contact
DR EZI MECHA: has conducted regular meetings with stakeholders in an effort to determine and
assess the real needs on the ground. She has been collecting donations of good, service and funds to
support the real need of communities in affected areas. Contact
MARK ZUCKERBERG: Creator of FACEBOOK, has personally donated $25 million to CDC and
his FACE BOOK has been a lifeline in reporting about Ebola development in affected areas. Thanks!
NOTABLE AND NOTEWORTHY CONTRIBUTION

67. EXPERIMENTAL EBOLA VACCINES
October 2014: Mechanisms for evaluating and sharing data in real time must be prepared and
agreed upon and the remainder of the phase 1 trials must be started
October November 2014: Agreed common protocols (including for phase 2 studies) across
different sites must be developed
October November 2014: Preparation of sites in affected countries for phase 2 b should start
as soon as possible
November December 2014: Initial safety data from phase 1 trials will be available
January 2015: GMP (Good Manufacturing Practices) grade vaccine doses will be available for
phase 2 as soon as possible
January February 2015: Phase 2 studies to be approved and initiated in affected and non-
affected countries (as appropriate)
As soon as possible after data on efficacy become available:
Planning for large-scale vaccination, including systems for vaccine financing, allocation, and use.

69. EXPERIMENTAL EBOLA VACCINES
October 2014: Mechanisms for evaluating and sharing data in real time must be
prepared and agreed upon and the remainder of the phase 1 trials must be started
October November 2014: Agreed common protocols (including for phase 2 studies)
across different sites must be developed
October November 2014: Preparation of sites in affected countries for phase 2 b
should start as soon as possible
November December 2014: Initial safety data from phase 1 trials will be available
January 2015: GMP (Good Manufacturing Practices) grade vaccine doses will be
available for phase 2 as soon as possible
January February 2015: Phase 2 studies to be approved and initiated in affected and
non-affected countries (as appropriate) As soon as possible after data on efficacy
become available: Planning for large-scale vaccination, including systems for vaccine
financing, allocation, and use.

70. PROMISING VACCINES
Given the public health need for safe and effective Ebola
interventions, WHO regards the expedited evaluation of all Ebola
vaccines with clinical grade material as a high priority. Two
candidate vaccines have clinical-grade vials available for phase 1
pre-licensure clinical trials.
One (cAd3-ZEBOV) has been developed by GlaxoSmithKline in collaboration with the US National
Institute of Allergy and Infectious Diseases. It uses a chimpanzee-derived adenovirus vector with an
Ebola virus gene inserted.
The second (rVSV-ZEBOV) was developed by the Public Health Agency of Canada in Winnipeg. The
license for commercialization of the Canadian vaccine is held by an American company, the
NewLink Genetics company, located in Ames, Iowa. The vaccine uses an attenuated or weakened
vesicular stomatitis virus, a pathogen found in livestock; one of its genes has been replaced by an
Ebola virus gene.

71. USAID is the lead agency for the overall U.S. Response to the Ebola epidemic in west
emergency assistance to contain the epidemic, address humanitarian needs and support
the recovery of affected countries in the region.
Ideas
The USAID is calling on the global community to quickly deliver practical and cost-effective innovations that can help
healthcare workers on the front lines provide better care and stop the spread of Ebola. Learn more about Fighting
Ebola: A Grand Challenge for Development
• Medical Volunteers: click here to contact reputable organizations who are active in the Ebola response
• introductory safety training course for licensed clinicians intending to work in an Ebola Treatment Unit (ETU) in
Africa.
• care and evacuation of international medical responders.
Diaspora Outreach
USAID is working to ensure that Sierra Leonean, Liberian, Guinean and other diaspora organizations/individuals in the
US are well informed about the US government's response to the Ebola outbreak and how they might be engaged.
signup form for interested individuals and groups who want to receive regular
updates from USAID.
WHERE TO FIND UPDATED INFORMATION ON US RESPONSE

72. Useful links
Ebola Crisis Page
WHO Ebola Portal
UN Global Ebola Response
CDC Ebola
MEDBOX Ebola Toolbox
Ebola alerts on Health Map
OpenStreetMap West Africa Ebola Response
Ebola Response Anthropology Platform
2014 Ebola Outbreak: Full Coverage of the Viral Epidemic
Ebola Response MPTF

73. Please help mobilize a fresh understand
responsibilities in the universal ecosystem and help
generate consensus for right action.
African Views Appeal to the World Public

74. Send a letter to your representatives
Start a campaign
Raise awareness at your school and community
Discuss among your constituencies and follow through
The message is simple :
(#africanhealthinstitutes)
What you can do to help?

75. Build sustainable African Health Institutes
Expectation
What Will It Take?
Multi-lateral Negotiation, Multi-Partnership Investment
Agreement and Integrated Intelligence Resource Coordination